Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Operating Expenses | 1,705 | 1,505 | 1,284 | 1,067 | 1,365 |
| Operating Income | -1,705 | -1,505 | -1,284 | -1,067 | -1,365 |
| Other Income | -39 | 1,429 | -1,338 | 778 | 276 |
| Pre-tax Income | -1,744 | -77 | -2,622 | -289 | -1,089 |
| Net Income Continuous | -1,744 | -77 | -2,622 | -289 | -1,089 |
| Net Income | $-1,744 | $-77 | $-2,622 | $-289 | $-1,089 |
| EPS Basic Total Ops | -0.04 | -0.01 | -0.08 | -0.01 | -0.04 |
| EPS Basic Continuous Ops | -0.04 | 0.00 | -0.08 | -0.01 | -0.04 |
| EPS Diluted Total Ops | -0.04 | -0.01 | -0.08 | -0.01 | -0.04 |
| EPS Diluted Continuous Ops | -0.04 | 0.00 | -0.08 | -0.01 | -0.04 |
| EBITDA(a) | $-1,700 | $-1,503 | $-1,281 | $-1,065 | $-1,362 |